Pharmacokinetics, Clinical Efficacy, Safety Profile, and Patient-Reported Outcomes in Patients Receiving Subcutaneous Testosterone Pellets 900 mg for Treatment of Symptoms Associated With Androgen Deficiency
2017 ◽
Vol 14
(7)
◽
pp. 883-890
◽
Keyword(s):
2014 ◽
Vol 28
(12)
◽
pp. 1707-1715
◽
Keyword(s):
2018 ◽
Vol 50
(10)
◽
pp. 1019-1029
◽
Keyword(s):